Researchers in Switzerland present a high-throughput method for developing and refining selected reaction monitoring assays to detect human proteins. Writing in Science Translational Medicine, the team reports applying its SRM-based approach to detect cancer-associated proteins in plasma and urine samples. "Moreover, we demonstrate that these SRM assays allow reproducible quantification by monitoring 34 biomarker candidates across 83 patient plasma samples," the authors write.